Actor
ChondroNest SA
In vivo reconstruction of the scaffold of the Extra Cellular Matrix – ECM – with mechanical and biocompatible properties based on the natural biopolymers of living tissues.
The intellectual property filed is centred on an innovative chemical approach for the modification of the proteins (Collagens, Fibronectins, etc) and Glycosaminoglycans (Hyaluronic acid, Chondroitin sulphate, and so forth).
Specialties
Primary Therapeutic Areas
1.09 Proteins & Peptides
1.5 Medical Technology
1.52 Diagnostic & In-Vitro Device
1.61 Orthopaedic & Rehabilitation
Business model
1. Entreprise
1.1 Start-Up
Organization Type
Private Company
Visit website
Domains
Musculoskeletal & Inflammation
Main sector
Biotech
Contact
Rue des Eterpys 22
1964 Conthey / VS